Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$2.3B
30M shares
52-week range
$35.80 – $97.59
64% from low
Sector
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Exchange
NASDAQ
CS
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
establishmentlabs.comNo one on the platform currently holds ESTA.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 55,800 | $3.2M |
No one on the platform has traded ESTA yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$ESTA Citigroup upgrades from neutral to buy with 92 target. Some premkt volume as a result.
View on StockTwits ↗$ESTA so far holding the 75 spot, which was obvious. We'll see if mm want to push this lower. Good add spot.
View on StockTwits ↗$ESTA Added significantly in mid 70s. Now my largest holding.
View on StockTwits ↗$ESTA Just bought back my shares I trimmed in the upper 80s. Currently holding 500 shares. Breast implants for the win and Motiva is the Queen of the boob job market! $SPY $QQQ $ABBV $JNJ
View on StockTwits ↗$ESTA Their business is rolling along w GP% higher by 200BP yoy impressive … The issue is that they have been telling us for quite some time that they would be cash flow positive… Investors are losing patience ….
View on StockTwits ↗$ESTA bought a number of shares across three accounts today. This is following the standard pattern and while it ran hot. I’m okay holding as it will continually outperform in its market, and THE market
View on StockTwits ↗$ESTA peace to all but hope the 3 day rule drops this back into 60’s because i want to buy big
View on StockTwits ↗Earnings season can be unforgiving. One report can completely change a stock’s setup. $APP, $BROS, $ESTA, and $BLLN show why preparation matters. Even strong companies can face major moves when expectations meet reality. Volatility creates opportunities, but only with the right plan and risk control. I’ll keep tracking earnings, price action, and key setups. Check my profile for more real-time market insights.
View on StockTwits ↗$ESTA as anticipated. Seeing a case for this to push down towards 75 ish area but quarterly report proves their growth is on track. Would probably look to add a small amount in mid 70s, if we get there.
View on StockTwits ↗$ESTA Establishment Labs (NASDAQ: ESTA) Buy (1) Price Target: $117.00 The Stock Is Down, but Our Revenue Estimates Move Up; Reiterate Buy THE TD COWEN INSIGHT ESTA shares are down following a largely positive print with key elements of our bull thesis still intact: U.S. and MIS momentum. We view this as a buying opportunity before ESTA benefits further from the steep Preservé training ramp (>300 U.S. surgeons), U.S. new account momentum (now >2,000), and growing utilization, which should drive outperformance and sustained Adj. EBITDA profitability.
View on StockTwits ↗$ESTA still think this is a buyout contender in the 120s
View on StockTwits ↗$ESTA bad earnings, management selling, i think we see $70 soon
View on StockTwits ↗$ESTA Low volume drop is great buying opportunity, IMO. I have been adding in mid 80s
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $268M | +27.2% | $-1.15 | $-1.29–$-1.07 | — | 4 |
| 2027 | $338M | +26.2% | $0.02 | $0.00–$0.02 | 4674.4× | 4 |
| 2028 | $417M | +23.6% | $1.14 | $0.81–$1.99 | 66.5× | 9 |
| 2029 | $528M | +26.5% | $2.34 | $2.30–$2.42 | 32.3× | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ESTAEstablishment Labs Holdings Inc. | $75.59 | +0.01% | $2.2B | — |
| AHCOAdaptHealth Corp. | $5.70 | -1.21% | $776M | — |
| AZTAAzenta, Inc. | $33.91 | +1.13% | $1.6B | — |
| CNMDCONMED Corporation | $49.82 | +0.69% | $1.5B | — |
| KMTSKestra Medical Technologies, Ltd. | $27.74 | -0.93% | $1.6B | — |
| NVCRNovocure Ltd | $17.38 | -1.19% | $2.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
| SSIISS Innovations International, Inc. | $3.83 | +3.79% | $767M | — |